Skip to content

Visual Outcomes and Satisfaction comaprison in patients undergoing Intraocular lens implantation via Phacoemulsification.

Visual Outcomes and Satisfaction in patients undergoing Monofocal Intraocular lens (IOL) Vs Multi-Focal IOL Vs Extended Depth of Focus (EDOF) IOL Implantation via Phacoemulsification. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065438
Enrollment
141
Registered
2024-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Control Intervention1: NIL: NIL

Sponsors

Aravind Eye Hospital Chennai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A) Patients aged 40 and above. B) Patients advised surgery, consenting and willing to undergo cataract surgery by phacoemulsification / MICS. C) Uneventful phacoemulsification / MICS surgery

Exclusion criteria

Exclusion criteria: A) Patients with chronic co-morbidities like Diabetes Mellitus, Hypertension. B) Any pre-existing corneal pathology/opacity leading to altered vision. C) Any pre-existing retinal or macular pathology leading to sub-optimal post-op vision. D) Inherited ocular conditions leading to Guarded visual prognosis. E) Previously IOL implanted patient undergoing lens exchange procedure.

Design outcomes

Primary

MeasureTime frame
Visual Acuity differences across Near, Intermediate and Far vision will be measured and compared across Monofocals, Multifocals, EDOF IOLs. Multifocals should give spectacle free good visual acuity across all ranges. EDOF good visual acuity across Far and Intermediate vision.Timepoint: Post Operative Day 1, Post Operative Day 21 (3rd week), Post operative Day 90 (3rd month)

Secondary

MeasureTime frame
Patient satisfaction via IND-VFQ questionnaire on post operative visit. -Spectacle independence -Any adverse events related to the IOLs (glare, haloes, astigmatism, aberrations via iTrace.Timepoint: POD 1, 21 and 3rd month

Countries

India

Contacts

Public ContactManan Mistry

Aravind Eye Hospitals

haripriya@aravind.org9442643561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026